The expression levels of early HCC markers BIRC5, HSP70, LYVE and EZH2, angiogenesis marker VEGFA and immune checkpoint CD274 significantly correlated with both central tendency and heterogeneity parameters. Here, EZH2 is linked to hepatocellular carcinoma.